| The relationship between the drug
business, drugs and personal injury has been the focus of our firm for
the past two decades. Almost every catastrophic personal injury case
requires an in depth understanding of the medical use of drugs, the
toxic (poisonous) effects of drugs and what chemical reactions occur
within the body when drugs are mixed (the synergistic effects of drugs)
and how drug companies do business in America.
The study of the effects of drugs on the
human bio-chemical system is very important to determining the liability
of drug manufacturers, or medical providers. For example, in one case,
our client was treated at a hospital for severe injuries to his hand.
After emergency surgery he was admitted to the hospital. Several hours
later, while recovering from surgery he was discovered by the nursing
staff in a coma. He eventually awoke from the coma, but had suffered so
much brain damage, he is now a quadriplegic. The hospital investigation
concluded that the reason he went into a coma was a mystery. The
hospital argued that review of all medications administered and
evaluations performed were appropriate. When we were asked to review the
case, the first thing we did was review the medication administration
records. We quickly learned that he was given large (but normal) amounts
of morphine for the pain. However, he was also given oral Valium at the
same time. Both of these medications alone have the effect of
suppressing the Central Nervous System. When combined, they increase
that effect dramatically that they can induce a coma.
The manufacturer of the morphine and the
self dispensing equipment given to the patient did not warn of this
problem. Eventually we recovered several million dollars on the case.
Understanding how these drugs work and our experience helps us to
understand how drug manufacturers test, or fail to test drugs adequately
before promoting them to market.
The pharmaceutical business is extremely
competitive and highly profitable. To the pharmaceutical manufacturer,
the profit to be made from just one successful drug far outweighs the
cost that the company may have to pay in damages to someone who is
adversely affected by the drug. This 'cost versus benefit' way of
thinking has allowed drug companies to place drugs on the market that
they know can have serious life threatening consequences to certain
people. The problem is that the companies have been allowed to police
themselves and almost always understate the number of people affected by
the known complications when reporting to the FDA for approval. The FDA
is pressured into giving approval and the company's cash register starts
charging.
The lawyers who take on these companies and
their practices have developed a keen understanding of the
pharmaceutical business and what we need to prove to beat them at their
own game. The task is monumental, but the cause is more than worthy. |